cesarean section site infection

Evaluation of the effect of combined antibiotic regimen of cefazolin and azithromycin in comparison with cefazolin antibiotic regimen on the incidence of non-emergency cesarean section infection

Status

Recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20220223054104N1

Enrollment

204

Registered

2022-05-09

Start date

2022-05-21

Completion date

Unknown

Last updated

2022-05-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Surgical site infection. Infection following a procedure, subsequent encounter

Interventions

Intervention 1: Intervention group: All patients will have a bath with antibacterial soap the night before the operation, and the hair on the area before the operation and before the operation will be

Eligibility

Sex/Gender

Female

Inclusion criteria

Inclusion criteria: All women candidate for elective cesarean section in Mahdie hospital

Exclusion criteria

Exclusion criteria: Patients who do not consent to participate in the study.

Design outcomes

Primary

Measure	Time frame
Incidence and prevalence of cesarean section site infection. Timepoint: From the time of cesarean section until 30 days later. Method of measurement: Clinical evidence and signs of surgery site infection including fever and chills, erythema, warmth, tenderness, swelling, purulent discharge from the incision site, uterine tenderness and purulent vaginal discharge 24 and 48 hours after surgery and on days 10 and 30 after The action is evaluated by the researcher.	—

Measure

Time frame

Incidence and prevalence of cesarean section site infection. Timepoint: From the time of cesarean section until 30 days later. Method of measurement: Clinical evidence and signs of surgery site infection including fever and chills, erythema, warmth, tenderness, swelling, purulent discharge from the incision site, uterine tenderness and purulent vaginal discharge 24 and 48 hours after surgery and on days 10 and 30 after The action is evaluated by the researcher.

—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMahsa Eskandari

Shahid Beheshti University of Medical Sciences

mahsaeskandariuni@gmail.com+98 21 4483 4648

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026